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Abstract There is paucity of data on Enhanced Recovery
After Bariatric Surgery (ERABS) protocols. This feasibility
study reports outcomes of this protocol utilized within a
tertiary-referral bariatric centre. Data on consecutive primary
procedures (laparoscopic gastric bypasses, sleeve gastrectomies
and gastric bands) performed over 9 months within an ERABS
protocol were prospectively recorded. Interventions utilized
included shortened preoperative fasts, intra-operative humidifi-
cation, early mobilization and feeding, avoidance of fluid over-
load, incentive spirometry, use of prokinetics and laxatives.
Data collected included demographics, co-morbidities, morbid-
ity, mortality, length of stay (LOS) and re-admissions. A total of
226 procedures (age [mean ± SD], 45±11 years, median [in-
terquartile range] BMI 44.9 [41.0–49.0] kg/m2) were undertak-
en: 150 (66 %) bypasses, 47 (21 %) sleeves and 29 (13 %)
bands. Hypertension, diabetes mellitus, sleep apnea and limited
mobility were present in 40 %, 34%, 24 % and 9% of patients,
respectively. No anastomotic or staple line leaks/bleeds were
encountered. Ten (4.4 %) patients developed postoperative
morbidity (mainly respiratory complications). One death
occurred from massive pulmonary embolus in a high-risk pa-
tient (despite insertion of preoperative-IVC filter). Respective
mean ± SD LOS for bypasses, sleeves and bands were 1.88±
1.12, 2.30±1.69 and 0.69±0.81 days. Successful discharge on
the first postoperative day was achieved in 37 % and 28 % of
bypasses and sleeves, respectively. Day-case gastric bandswere
performed in 48 %. Thirty-day hospital re-admission occurred
in six (2.7 %) patients. Applying an ERABS protocol was
feasible, safe, associated with low morbidity, acceptable LOS
and low 30-day re-admission rates. The presence of multiple
medical co-morbidities should not preclude use of an ERABS
protocol within bariatric patients.
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Introduction
Enhanced Recovery After Surgery (ERAS) pathways integrate
multimodal perioperative interventions which are designed to
reduce physiological stress, facilitate early return of bodily
function and reduce healthcare costs by reducing length of
hospital stay (LOS) [1]. Much of the evidence for ERAS has
been derived from patients undergoing lower gastrointestinal
surgery. A meta-analysis of outcomes of patients undergoing
major elective open colorectal surgery within an ERAS path-
way, compared to conventional perioperative care, demonstrat-
ed ERAS pathways to be associated with significantly reduced
postoperative complication rates (relative risk 0.53 [95 % con-
fidence interval 0.41–0.69], P<0.00001) and LOS (weighted
mean difference −2.51 days [95 % CI, −3.54 to −1.47],
P<0.00001) [2]. There is, however, paucity of ERAS data
originating from patients undergoing bariatric and metabolic
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surgery [3]. Indeed, the only published study from the United
Kingdom was an observational case series of 406 laparoscopic
Roux en-Y gastric bypass (LRYGB) patients that described a
'fast-track' anesthetic pathway [4]. However, the latter investi-
gators did not utilize traditionally described ERAS interven-
tions [1]. A recently reported randomized clinical trial exam-
ined an enhanced recovery pathway versus standard care fol-
lowing 78 patients undergoing laparoscopic sleeve gastrectomy
[5]. In the latter study patients in the ERAS group demonstrated
significantly shorter LOS and reduced hospital costs with no
increase in occurrence of complications, although there was a
20 % re-admission rate in both ERAS and control groups [5].
Reasons for the delayed adoption of ERAS pathways within
bariatric centres may include lack of robust evidence within this
group of patients and concerns regarding the presence of com-
plex high-risk medical co-morbidities that require specialist
perioperative care. The aims of the present study were, there-
fore, to determine the feasibility and clinical outcomes follow-
ing implementation of an Enhanced Recovery After Bariatric




This prospective study collected data on consecutive patients
undergoing primary bariatric procedures (LRYGB, sleeve
gastrectomy and gastric banding) within an ERABS pathway.
Procedures were performed over a 9-month period (15 April
2012 to 15 January 2013) at Imperial Weight Centre
(London), a regional high-volume tertiary referral bariatric
centre that employed four consultant bariatric surgeons and a
bariatric fellow. The study had approval from the hospital
regulatory authorities.
Data Collection
Prospectively collected data included demographic details,
baseline co-morbidities, operation performed and LOS. Data
on occurrence of complications, mortality, re-admissions and
re-operations were extracted retrospectively from medical
case notes and emergency patient admission lists. The census
date for data collection was 1 February 2013 (and included
patients operated on until 15 January 2013). Data are present-
ed as mean ± SD or median (interquartile range, IQR) as
appropriate.
Patient Enrolment
At the time of the study, regional National Health Service
(NHS) commissioning criteria for bariatric surgery were
followed. Surgery was indicated for patients with body mass
index (BMI) ≥35 kg/m2 in the presence of obesity-related
medical co-morbidities (defined as difficult to control hyper-
tension, type 2 diabetes mellitus, obstructive sleep apnea or
polycystic ovary syndrome). The direct surgical pathway uti-
lized at Imperial Weight Centre included attendance at a patient
seminar where information (oral and written) was delivered (by
both a metabolic physician and bariatric surgeon) on the vari-
ous medical and surgical treatments for morbid obesity. Thence
followed attendance at a multi-disciplinary one-stop bariatric
clinic where within a group setting, patients received presenta-
tions delivered by specialist obesity dieticians and clinical nurse
specialists describing the perioperative pathway. They were
also issued with the appropriate dietary advice sheets and
incentive spirometers, ensuring they were familiarized with
use of the latter. Pending surgical, medical and anesthetic
reviews patients watched a Bariatric Surgery DVD to reiterate
indications and expected outcomes from surgery. This ensured
sufficient background knowledge was imparted prior to the
medical and surgical reviews. Preoperative assessment was
subsequently undertaken by a consultant bariatric anesthetist,
a metabolic physician and a bariatric surgeon. Appropriate
consultations with supporting specialties (renal, cardiac, respi-
ratory and psychiatry physicians) were arranged as indicated.
Patients with diabetes mellitus were reviewed by the metabolic
physician and their medications adjusted to ensure optimized
diabetes control preoperatively. All patients were listed for
surgery once any necessary preoperative 'work-up' was com-
pleted and reviewed by the multi-disciplinary team. All patients
undergoing primary surgery, who lived within a 2-h commute
from the hospital (approximately 30 miles distance), and had
appropriate home social support (an adult to care for them
postoperatively) were included into the ERABS pathway. Oth-
erwise, exclusion criteria included presence of renal (CKD III),
cardiac or liver failure that necessitated postoperative admission
to a high dependency unit or being wheelchair-dependent.
Whilst most ERABS interventions were still utilized in exclud-
ed patients, postoperative analgesia, fluid requirements, mobi-
lization and early discharge goals were tailored in a patient-
specific manner.
ERABS Interventions
In accordance with the principles of multimodal ERAS path-
ways utilized in patients undergoing elective colorectal sur-
gery [1], the ERABS pathway utilized at our bariatric centre
(Fig. 1) included preoperative, intraoperative and postopera-
tive interventions. Preoperative interventions included: exten-
sive perioperative counselling, shortened fluid fasts (intake of
clear liquids permitted up to 2 h pre-operatively) [6], and
optimized operating schedules whereby patients were sched-
uled on operating lists onMondays, Wednesdays and Fridays,
based on their co-morbidities and anticipated postoperative
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specialist medical reviews and LOS. Patients with potential
for day case discharge (e.g., gastric bands) were scheduled
first on the operating list, whilst patients with complex co-
morbidities were scheduled on Mondays and Wednesdays;
anticipating specialist inpatient reviews which would be dif-
ficult to arrange during the weekend. As data on preoperative
carbohydrate treatment were limited in the bariatric popula-
tion [7] we did not utilize this intervention in this feasibility
study. Patients undertook a preoperative low carbohydrate
(800 kcal/day) liver-shrinking diet for a period of 2–4 weeks
preoperatively (depending on preoperative BMI and sex).
Intraoperative interventions included an optimized bariatric
anesthesic protocol that included ramped head-up intubation
and extubation, avoidance of long acting opioids (instead
remifentanil was utilized intraoperatively), multimodal anal-
gesia (use of intravenous Paracetamol, Diclofenac and Tram-
adol), volume controlled ventilation, use of high PEEP (6–
8 cm/H2O) and permissive hypercapnea (end tidal CO2
>6.5 kPa) the latter used for its vasodilatory effects (to allow
intra-abdominal bleeding to be detected intraoperatively). Fur-
thermore, no steroids or benzodiazepines were utilized intra-
operatively, and the BIS EEG VISTA™ Monitor System
(Aspect Medical Systems, Massachusetts, USA) was used to
guide and minimize intraoperative anesthetic requirements
(BIS to less than 60). Patients typically received 1.5–2 l of
crystalloid infusion intraoperatively and local anesthetic was
infiltrated at surgical port sites at the start and end of surgery
(typically, a total of 40 ml 0.25% Bupivacaine with 1:200,000
Adrenalin was used). Intraoperative humidification and
heating of insufflated CO2 gas using the HumiGard™ system
(Fisher & Paykel Healthcare Ltd, Auckland, New Zealand)
was also used as in our experience of this intervention,
patients developed less postoperative pain and use of humid-
ified warmed CO2 reduced laparoscopic lens fogging enhanc-
ing speed and clinical efficiency. Alongside the WHO check-
list, a dedicated bariatric patient 'time-out' was undertaken
identifying patient-specific co-morbidities to the theatre team.
Patients were positioned at 60° reverse Trendelenburg to
ensure optimal intraabdominal space was available in the
supracolic compartment. Laparoscopic RYGB were per-
formed in an antecolic–antegastric fashion (typically 50 cm
biliopancreatic limb, 100 cm Roux limb length) using an end-
to-side (but functional end-to-end) linear stapled gastrojejunal
anastomotic technique. Sleeve gastrectomies were sized using
a 34F orogastric tube and utilizing Seamguard® (GORE®)
staple line reinforcement. The pars flaccida approach was
used to place gastric bands and a gastro-gastric tunnel was
formed in all cases to reduce the incidence of band slippage.
Nasogastric tubes and urinary catheters were not routinely
used and use of surgical drains was reserved for patients
whom the surgeon considered at increased postoperative risk
of bleeding. Postoperative interventions included protocol-
based care using a didactic protocol (Fig. 2) that ensured full
Fig. 1 Perioperative Enhanced Recovery After Bariatric Surgery
(ERABS) interventions used in this study
Fig. 2 Postoperative medical and nursing protocol used following gastric
bypass and sleeve gastrectomy
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mobilization within 4 h of the end of surgery, hourly use of
incentive spirometry, a postoperative intravenous fluid bal-
ance regimen that avoided fluid overload (previously shown
to delay return of gut function [8]) and the administration of
regular multimodal (opiate sparing) analgesia (intravenous
Paracetamol 1 g QDS, Tramadol melts 50–100 mg QDS),
antiemetics (Ondansetron 4 mg TDS), prokinetics
(Metoclopromide 10 mg TDS), and laxatives (Lactulose
15 ml BD). Compliance with the aforementioned post-
operative interventions was ensured by asking nursing staff
to sign opposite each intervention used. Although not formal-
ly assessed, lack of compliance with these interventions oc-
curred in only a few patients when certain devices/drugs were
out of stock on the surgical ward. A subcutaneous insulin
sliding scale regimen was used postoperatively for type 2
diabetic patients with good effect and avoided problems with
maintaining 'insulin-exclusive' additional intravenous access
postoperatively in these patients. Patients were reviewed post-
operatively three times daily by the bariatric fellow at 7:30AM,
1PM and 4:30PM to ensure appropriate clinical and discharge
concerns were addressed early. Liquid diet was commenced
on the first postoperative day without need for routine contrast
studies to confirm anastomotic integrity. The latter, however,
were selectively used in patients in whom an unsatisfactory
intra-operative air-leak test was obtained or when clinically
indicated postoperatively. Written discharge information
sheets were issued to patients on the morning ward round on
the first postoperative day to ensure sufficient time to read and
understand information contained therein. Information on the
postoperative recovery, diet, alarm symptoms, and a dedicated
24-h emergency bariatric mobile number were also issued to
patients. Discharge criteria included the presence of all of: (1)
able to drink 1.5 l of fluid per day and tolerating liquid diet; (2)
pain adequately controlled with oral analgesia; (3) adequate
mobilization; (4) presence of a supervising adult at home; and
(5) understand and accept the written information sheets pro-
vided. Early postoperative clinical review (proforma-guided)
on day 10 was undertaken by the bariatric clinical nurse
specialists who had access to an immediate bariatric surgical
consult if necessary; with the aim of eliciting early postoper-
ative concerns and to reiterate postoperative dietary instruc-
tions to patients.
Results
During the 9-month study period a total of 280 bariatric
procedures were performed. Of these 226 (80.7 %) primary
bariatric procedures were undertaken and included in the
present study. The remaining 54 patients underwent
revisional surgery or met the aforementioned exclusion
criteria. There were 150 (66 %) LRYGB, 47 (21 %) sleeve
gastrectomies and 29 (13 %) gastric bands. No patients
enrolled within the ERABS pathway were subsequently
excluded operatively or postoperatively. Baseline demo-
graphic and co-morbidity data are shown in Table 1. All
procedures were successfully completed laparoscopically.
No anastomotic or staple line leaks/bleeds were encoun-
tered in this series. Postoperative morbidity and LOS are
given in Table 2. One postoperative death occurred at 36 h
postoperatively. The latter resulted from massive pulmonary
embolus that occurred in a high-risk patient (previous his-
tory of pulmonary embolus) despite insertion of preopera-
tive IVC filter and postoperative anticoagulation with low
molecular weight heparin and use of intermittent pneumatic
compression device. One diagnostic re-laparoscopy at 48 h
was performed for suspected intra-abdominal sepsis follow-
ing sleeve gastrectomy and extensive adhesiolysis, howev-
er, no abnormalities were found at surgery (30-day re-
operation rate 0.4 %). Thirty-day hospital re-admissions
occurred in six (2.7 %) patients due to development of
non-specific abdominal pain (all investigations negative,
three patients), constipation (one patient), diarrhea and de-
hydration due to lactose intolerance that developed 3 weeks
post LRYGB (one patient) and extensive lower limb deep
venous thrombosis that followed an unsuccessful attempt at
removing a temporary IVC filter (one patient).
Discussion
This prospective study has demonstrated that implementing
an ERABS pathway was feasible, safe and associated with
low 30-day complication (4 %) and hospital re-admission
(2.7 %) rates. Our pragmatic study design set out to determine
whether implementation of an ERABS pathway in a 'real-life'
Table 1 Baseline demographic and co-morbidity data for the 226 par-
ticipants of this study
Age, mean ± SD (years) 45±11
Sex (%) 163 female (72 %)
Overall BMI, median (IQR) kg/m2 44.9 (41.0–49.0)
▪ Gastric bypass patients 44.7 (41.6–48.0)
▪ Sleeve gastrectomy patients 45.0 (41.2–50.7)
▪ Gastric band patients 43.0 (38.8–49.9)
Medical co-morbidity, number (%)
▪ Hypertension 90 (40 %)
▪ Type 2 diabetes mellitus 77 (34 %)
▪ Obstructive sleep apnea 54 (24 %)
▪ Limited mobilitya 20 (9 %)
IQR interquartile range
a Limited mobility patients used walking sticks or frames to mobilize due
to arthritis or back pain. Wheelchair-bound patients were excluded from
enrolment into the Enhanced Recovery pathway
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setting would lead to outcomes equivalent to those seen within
a research setting [5]. As such we deliberately limited the
exclusion criteria to ensure most patients encountered in clinic
would be eligible for inclusion. Similarly, patients operated on
Fridays were not excluded from the series despite the likeli-
hood that their discharge may have been delayed whilst cared
for by the weekend emergency surgical teams (as opposed to
usual bariatric team).
At the time of this study, local NHS commissioning and
eligibility criteria for bariatric surgery required presence of
BMI≥35 kg/m2 along with presence of an obesity-related
co-morbidities. Thus the majority of patients in this series
had a combination of poorly controlled hypertension, dia-
betes mellitus and obstructive sleep apnea. Almost 10 % of
the series had poor mobility, a factor that may have ham-
pered postoperative mobility, recovery and resulted in de-
layed discharge. That said, mean LOS was 1.88 and
2.30 days for LRYGB and sleeve gastrectomy patients,
respectively. Furthermore, almost a third of gastric bypass
and sleeve gastrectomy patients were successfully dis-
charged on the first postoperative day; and half of gastric
band patients were performed within a day-case setting.
Importantly, these results were achieved with an impressive
2.7 % 30-day hospital re-admission rate, which compares to
the 20 % readmission rate encountered in a recently report-
ed randomized study of sleeve gastrectomy patients within
an ERAS pathway [5]. Whilst it was theoretically possible
that patients may have presented postoperatively to other
hospitals this was unlikely as our patients were strongly
counselled to contact the emergency bariatric mobile (call
logs were kept) and re-present to our emergency department
in the event of any problems. Furthermore, postoperative
outpatient clinic review of these patients did not elicit atten-
dance at other hospitals.
We used traditional ERAS components within our pathway
accepting there was a relative lack of evidence base within the
bariatric population [3]. However, several of the components
included in our protocol had a strong evidence base from lower
gastrointestinal surgery [1] and as such are now widely con-
sidered best surgical practice. Specific components of tradi-
tional ERAS protocols [1] that were not included in our
protocol included preoperative carbohydrate treatment which
has been demonstrated in a recent meta-analysis to be associ-
ated with decreased LOS following major elective abdominal
surgery [7]. However, there are presently no studies examining
the gastric emptying and the metabolic effects of these precon-
ditioning drinks [9] within the bariatric population; of whom
up to a third (as in this series) may have diabetes mellitus.
Standardization of anesthetic protocols, surgical tech-
nique, and use of a didactic medical and nursing postop-
erative protocol may have contributed to the good clinical
outcomes (low complication and re-admission rates) en-
countered in this series. The later was developed from
experience gained at our bariatric centre over the past
7 years which included over 2,000 gastric bypasses and
500 sleeve gastrectomies. Of equal importance was the
unit policy to ensure patients were recovered postopera-
tively in dedicated bariatric beds that were manned by
bariatric-trained nursing staff. In keeping with this, there
is evidence that standardization of perioperative care may
be associated with improved outcomes [10]. Whilst signif-
icant variation exists within bariatric practice in the United
Kingdom [11], of more importance is the standardization
of unit policy to ensuring adequate induction and famil-
iarity of staff with protocols used therein. This study has a
number of limitations. Firstly, it lacks a control group with
which to compare outcomes from the ERABS pathway.
Similarly, we did not present data on LOS prior to imple-
mentation of the ERABS protocol, as the former were not
available. Secondly, postoperative LOS is used as a surro-
gate marker of recovery. Thirdly, we did not seek to
perform an economic analysis of the effects of ERABS,
however, this data has recently been reported from a
randomized trial [5].
Conclusion
This study has demonstrated that applying an ERABS proto-
col was feasible, safe, associated with low morbidity, accept-
able LOS and low 30-day hospital re-admission rates. The
presence of multiple medical co-morbidities should not pre-
clude use of such a protocol within bariatric patients.
Table 2 Postoperative morbidity and length of hospital stay
Postoperative morbidity, number of patients (%) 10 (4.4 %)
▪ Respiratory morbidity (5 LRTI, 1 type II respiratory
failure)
6
▪ Thromboembolic complications (one DVT, one PE) 2
▪ Post-operative bleed (dropped Hb, managed
conservatively)
1
▪ Postoperative morbidity, number of patients (%) 1
Length of hospital stay, mean ± SD (days)
▪ Gastric band 0.69±0.81
▪ Gastric bypass 1.88±1.12
▪ Sleeve gastrectomy 2.30±1.69
Day-case discharge successful for gastric band patients 14 (48 %)
Discharge successful on first postoperative day, number (%)
▪ Gastric bypass 56 (37 %)
▪ Sleeve gastrectomy 13 (28 %)
Presence of postoperative LRTI requiring antibiotic treatment was deter-
mined either clinically (newly developed cough productive of green/brown
phlegm with signs of sepsis) or radiologically (presence of pulmonary
opacities/infiltrates coupled with clinical signs in keeping with LRTI)
DVT lower limb deep venous thrombosis, Hb hemoglobin, LRTI lower
respiratory tract infection, PE pulmonary embolus
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